IP addresses and postal/email addresses are a match made in … not heaven. According to a new report, IP-to-email matches are accurate about 16% of the time on average, while IP-to-postal matches are ...

Gilead Sciences and Arcus Biosciences’ anti-TIGIT antibody domvanalimab has been tied to median overall survival of close to 27 months, keeping alive one of the last remaining hopes for this ...

Autism diagnosed in early childhood differs genetically and developmentally from autism identified later in an individual’s development, challenging the notion that it is a single, uniform disorder, ...

An increase in opioid use disorder was found in those who had commercial insurance, with those aged 31 to 40 years having the highest percentage of opioid use disorder. The Opioid Tracker includes a ...

This Repository consist of all the Jupyter Notebooks, Images and .CSV files of the tasks that were assigned during the Accenture Data Analytics Job Sim hosted on Forage ...

Members of a Senate panel described a haphazard working and living environment that involved transferring sensitive information to servers “without any verified security controls.” By Karoun Demirjian ...

SAN DIEGO, Sept. 16, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data from the Phase 2 SAVITRI study of osavampator in adults with major ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday shared data from the Phase 3 NIMBLE trial assessing investigational cemdisiran monotherapy in adults with generalized myasthenia gravis (gMG).

Tenaya Therapeutics is advancing two one-time gene therapies, TN-201 and TN-401, targeting genetic heart disorders with key data readouts expected in Q4 2025. Interim results for TN-201 in MYBPC3-HCM ...